IP Library Granted Patent US 8,889,390
Granted Patent B2
US 8,889,390 · App. 13/766,380 · Granted Nov 18, 2014

Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes

Inventors: Manju Gupta (Carmel, IN); Asha M. Palta (Carmel, IN); Stephen Novak (Westfield, IN); Fyodor Urnov (Richmond, CA); Sunita Gopalan (Alameda, CA)
Assignees: Dow AgroSciences LLC; Sangamo BioSciences, Inc.
C12N15/8213C07K2319/00C12N15/8243C07K2319/81C12N9/1092C12N15/8274
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,390
App. No.
13/766,380
Granted
Nov 18, 2014
Kind
B2
Abstract

The present disclosure relates to engineered zinc finger proteins that target 5-enolpyruvyl shikimate-3-phosphate synthase (EPSPS) genes in plants and methods of using such zinc finger proteins in modulating gene expression, gene inactivation, and targeted gene modification. In particular, the disclosure pertains to zinc finger nucleases for targeted cleavage and alteration of EPSPS genes.

Claims (5)

1. A donor vector comprising nucleic acid sequences having homology to chromosomal 5-enolpyruvyl shikimate-3-phosphate synthase (EPSPS) DNA sequences, said nucleic acid sequences comprising a first, second and a third DNA sequences; wherein the first and second sequences comprise a sequence as shown in any one of SEQ ID NOs: 141, 142, and 144-153; and the third sequence is interposed between the first and second sequences and comprises an exogenous sequence.

2. The donor vector of claim 1 , wherein the third sequence comprises sequences encoding a selectable marker.

3. The donor vector of claim 2 , wherein the selectable marker is selected from the group consisting of green fluorescent protein (GFP), β-glucuronidase (GUS), phosphinothricin N-acetyl transferase (PAT, BAR), neomycin phosphotransferase, hygromycin phosphotransferase, β-lactamase, catechol dioxygenase, α-amylase, tyrosinase, β-galactosidase, luciferase, aequorin, EPSP synthase, nitrilase, acetolactate synthase (ALS), dihydrofolate reductase (DHFR), dalapon dehalogenase and anthranilate synthase.

4. The donor vector of claim 1 , wherein the third sequence comprises sequences selected from the group consisting of a sequence encoding a protein other than a selectable marker; one or more transcriptional regulatory sequences; one or more sequences which enhance or diminish protein targeting; one or more sequences encoding a portion of a protein; a small interfering RNA; and a micro RNA.

5. The donor vector of claim 4 , wherein the third sequence comprises a sequence encoding a mutant EPSPS chromosomal sequence that increases tolerance of a plant to the herbicide glyphosate.

Assignments (1)
CHANGE OF NAME Recorded Apr 18, 2019
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 048945/0320 →
Continuity (3)
Division 12284888 · Sep 25, 2008
Provisional Application 60995557 · Sep 27, 2007
Related Publication 20130145503A1 · Jun 6, 2013